237 related articles for article (PubMed ID: 16391853)
21. Lymphomatoid keratosis: an epidermotropic type of cutaneous lymphoid hyperplasia: clinicopathological, immunohistochemical, and molecular biological study of 6 cases.
Arai E; Shimizu M; Tsuchida T; Izaki S; Ogawa F; Hirose T
Arch Dermatol; 2007 Jan; 143(1):53-9. PubMed ID: 17224542
[TBL] [Abstract][Full Text] [Related]
22. Absent or low expression of T-cell receptor zeta-chain in T cells infiltrating human pathological skin conditions.
Alaibac M; Pigozzi B; Saponeri A; Belloni-Fortina A; Peserico A
Arch Dermatol Res; 2002 Nov; 294(8):380-2. PubMed ID: 12420108
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
24. Bcl-2-positive epidermal dendritic cells in inverted follicular keratoses but not squamous cell carcinomas or seborrheic keratoses.
Ko CJ; Kim J; Phan J; Binder SW
J Cutan Pathol; 2006 Jul; 33(7):498-501. PubMed ID: 16872473
[TBL] [Abstract][Full Text] [Related]
25. CD14+ antigen-presenting cells in human dermis are less mature than their CD1a+ counterparts.
Angel CE; Lala A; Chen CJ; Edgar SG; Ostrovsky LL; Dunbar PR
Int Immunol; 2007 Nov; 19(11):1271-9. PubMed ID: 17804688
[TBL] [Abstract][Full Text] [Related]
26. CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity.
Sieling PA; Jullien D; Dahlem M; Tedder TF; Rea TH; Modlin RL; Porcelli SA
J Immunol; 1999 Feb; 162(3):1851-8. PubMed ID: 9973451
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cells in T- and B-cell proliferation in the skin.
Pimpinelli N; Santucci M; Romagnoli P; Giannotti B
Dermatol Clin; 1994 Apr; 12(2):255-70. PubMed ID: 8045037
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours.
Hillenbrand EE; Neville AM; Coventry BJ
Br J Cancer; 1999 Feb; 79(5-6):940-4. PubMed ID: 10070894
[TBL] [Abstract][Full Text] [Related]
29. Where does the antigen of cutaneous sarcoidosis come from?
Kurata A; Terado Y; Izumi M; Fujioka Y; Franke FE
J Cutan Pathol; 2010 Feb; 37(2):211-21. PubMed ID: 19615023
[TBL] [Abstract][Full Text] [Related]
30. CD7 expression in reactive and malignant human skin T-lymphocytes.
Alaibac M; Pigozzi B; Belloni-Fortina A; Michelotto A; Saponeri A; Peserico A
Anticancer Res; 2003; 23(3B):2707-10. PubMed ID: 12894562
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cells and cutaneous T-cell lymphomas.
Ni X; Duvic M
G Ital Dermatol Venereol; 2011 Apr; 146(2):103-13. PubMed ID: 21505396
[TBL] [Abstract][Full Text] [Related]
32. Proliferative activity of CD8(+) T cells as an important clue to analyze T cell-mediated inflammatory dermatoses.
Deguchi M; Ohtani H; Sato E; Naito Y; Nagura H; Aiba S; Tagami H
Arch Dermatol Res; 2001 Sep; 293(9):442-7. PubMed ID: 11758786
[TBL] [Abstract][Full Text] [Related]
33. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
[TBL] [Abstract][Full Text] [Related]
34. CD1a and antitumour immune response.
La Rocca G; Anzalone R; Bucchieri F; Farina F; Cappello F; Zummo G
Immunol Lett; 2004 Aug; 95(1):1-4. PubMed ID: 15325791
[TBL] [Abstract][Full Text] [Related]
35. Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides.
Goteri G; Filosa A; Mannello B; Stramazzotti D; Rupoli S; Leoni P; Fabris G
J Clin Pathol; 2003 Jun; 56(6):453-8. PubMed ID: 12783973
[TBL] [Abstract][Full Text] [Related]
36. Indeterminate cell tumor: a rare dendritic neoplasm.
Rezk SA; Spagnolo DV; Brynes RK; Weiss LM
Am J Surg Pathol; 2008 Dec; 32(12):1868-76. PubMed ID: 18813122
[TBL] [Abstract][Full Text] [Related]
37. Value of the CD8-CD3 ratio for the diagnosis of mycosis fungoides.
Ortonne N; Buyukbabani N; Delfau-Larue MH; Bagot M; Wechsler J
Mod Pathol; 2003 Sep; 16(9):857-62. PubMed ID: 13679448
[TBL] [Abstract][Full Text] [Related]
38. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
39. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
40. Type and maturational status of dendritic cells in cutaneous B cell lymphoproliferative disorders.
Christie LJ; MacKenzie C; Palmer TJ; Baker L; Goodlad JR
Histopathology; 2011 Sep; 59(3):421-32. PubMed ID: 22034882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
